A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: trastuzumab [Herceptin]
Sponsor: Hoffmann-La Roche